申请人:THE UNIVERSITY OF BRITISH COLUMBIA
公开号:US20180064657A1
公开(公告)日:2018-03-08
Compounds having a structure of Formula I, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R
1
, R
2
, L
1
, L
2
, L
3
, X, a, b, c, n, and m are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity and uses as therapeutics as well as methods for treatment of subjects in need thereof, including prostate cancer are also provided.